abrdn Healthcare Investors (NYSE:HQH) Stock Crosses Above 50 Day Moving Average - What's Next?

Key Points

• HQH moved above its 50-day moving average of $21.09, reaching $21.47 before last trading at $21.245; its 200-day average is $20.32.
• The fund announced a quarterly dividend of $0.66 per share, equivalent to $2.64 annualized and a reported yield of 12.4%.
• Several institutional investors increased their holdings in the third quarter; institutional investors collectively own 32.60% of the fund’s shares.

abrdn Healthcare Investors (NYSE:HQH - Get Free Report) crossed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of $21.09 and traded as high as $21.47. abrdn Healthcare Investors shares last traded at $21.2450, with a volume of 116,987 shares traded.

abrdn Healthcare Investors Price Performance

The firm's 50-day simple moving average is $21.09 and its 200 day simple moving average is $20.32.

abrdn Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Monday, August 24th were paid a $0.66 dividend. The ex-dividend date was Monday, August 24th. This represents a $2.64 annualized dividend and a dividend yield of 12.4%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Kestra Advisory Services LLC boosted its position in abrdn Healthcare Investors by 15.8% during the third quarter. Kestra Advisory Services LLC now owns 152,632 shares of the financial services provider's stock worth $3,188,000 after purchasing an additional 20,832 shares during the period. MGO One Seven LLC increased its stake in shares of abrdn Healthcare Investors by 2.2% in the third quarter. MGO One Seven LLC now owns 41,104 shares of the financial services provider's stock worth $859,000 after purchasing an additional 878 shares in the last quarter. Oppenheimer & Co. Inc. increased its stake in shares of abrdn Healthcare Investors by 1.9% in the third quarter. Oppenheimer & Co. Inc. now owns 118,548 shares of the financial services provider's stock worth $2,476,000 after purchasing an additional 2,244 shares in the last quarter. Samalin Investment Counsel LLC raised its position in shares of abrdn Healthcare Investors by 17.9% in the third quarter. Samalin Investment Counsel LLC now owns 182,351 shares of the financial services provider's stock valued at $3,809,000 after purchasing an additional 27,735 shares during the period. Finally, Sage Capital Advisors llc raised its position in shares of abrdn Healthcare Investors by 56.4% in the third quarter. Sage Capital Advisors llc now owns 30,848 shares of the financial services provider's stock valued at $644,000 after purchasing an additional 11,121 shares during the period. Hedge funds and other institutional investors own 32.60% of the company's stock.

abrdn Healthcare Investors Company Profile

abrdn Healthcare Investors NYSE: HQH is a non-diversified, closed-end investment company focused on the global healthcare and life sciences industries. Rather than operating healthcare businesses directly, the fund invests in the securities of companies involved in areas such as pharmaceuticals, biotechnology, medical devices, healthcare services and related technologies.

The fund seeks long-term capital appreciation, with current income as a secondary objective. Its portfolio may include common and preferred stocks, convertible securities and other investments issued by healthcare companies at various stages of development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.